Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
548.05
+7.79 (+1.44%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
76
77
Next >
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
↗
July 01, 2024
The latest bull market has plenty of intriguing buying opportunities.
Via
The Motley Fool
2 Superior Growth Stocks to Buy if You Have $1,000 Right Now
↗
June 28, 2024
Growth stocks with wide moats and strong financials can compound investor returns with time.
Via
The Motley Fool
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
↗
June 28, 2024
These healthcare stocks have clear paths to growth over the next few years.
Via
The Motley Fool
2 Healthcare Stocks That Are Screaming Buys in June
↗
June 28, 2024
These top healthcare stocks are no-brainer buys in 2024 and beyond.
Via
The Motley Fool
You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever.
↗
June 27, 2024
Invest in the top biotech stocks to buy, as the sector pivots from pandemic-driven vaccine sales to solutions for chronic conditions.
Via
InvestorPlace
Peering Into Vertex Pharmaceuticals's Recent Short Interest
↗
June 26, 2024
Via
Benzinga
Investors seeking growth at a reasonable cost should explore NASDAQ:VRTX.
↗
June 20, 2024
NASDAQ:VRTX is not too expensive for the growth it is showing.
Via
Chartmill
13 Analysts Have This To Say About Vertex Pharmaceuticals
↗
June 17, 2024
Via
Benzinga
Should Quality-Oriented Investors Explore VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX)?
↗
June 12, 2024
Why NASDAQ:VRTX Stands Out as a Quality Stock.
Via
Chartmill
This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
↗
June 27, 2024
Via
Benzinga
Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued."
↗
June 27, 2024
The biotech's shares have traded sideways for over a year, but better days could be on the near-term horizon.
Via
The Motley Fool
3 Biotech Stocks That Could Make Your Grandchildren Rich
↗
June 27, 2024
These biotech stocks are poised to generate significant returns to investors due to their high growth potential.
Via
InvestorPlace
Everyone's Talking About Vertex Pharmaceuticals. Is It Time to Buy?
↗
June 25, 2024
It looks like Vertex's experimental new therapy could become a functional cure for lots of people with diabetes.
Via
The Motley Fool
Vertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes Presented at the American Diabetes Association 84th Scientific Sessions
June 21, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
$1000 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth This Much Today
↗
June 05, 2024
Via
Benzinga
This Is What Whales Are Betting On Vertex Pharmaceuticals
↗
June 03, 2024
Via
Benzinga
Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead
↗
June 21, 2024
Lilly is a good pick...but this one is better.
Via
The Motley Fool
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years
↗
June 18, 2024
Via
Benzinga
3 Top Stocks I'd Buy Today and Hold Forever Without Any Hesitation
↗
June 18, 2024
Evergreen business models make it easier to hold for the long run.
Via
The Motley Fool
Nvidia, AbbVie, Vertex Pharmaceuticals And An Oil Giant: CNBC's 'Final Trades'
↗
June 17, 2024
On CNBC's Halftime Report, Bryn Talkington picked NVIDIA, Jim Lebenthal chose Vertex Pharmaceuticals, Kevin Simpson named ConocoPhillips, and Rob Sechan suggested AbbVie, with all four stocks having...
Via
Benzinga
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
↗
June 15, 2024
Want peace of mind about your investments? Consider these great stocks.
Via
The Motley Fool
Vertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the 2024 Annual European Hematology Association (EHA) Congress
June 14, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
2 Healthcare Stocks to Buy Hand Over Fist in June
↗
June 12, 2024
They both have pretty impressive pasts, and their prospects look just as bright.
Via
The Motley Fool
Alphabet To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Tuesday
↗
June 11, 2024
Via
Benzinga
Healthcare And Biotech Investing: Breakthroughs In The Treatment Of Cancer At ASCO
↗
June 10, 2024
Healthcare stocks underperformed YTD because of weakness in UNH and strength in Technology and Communication Services.
Via
Talk Markets
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought
↗
June 09, 2024
These companies could generate explosive growth over time.
Via
The Motley Fool
Arcturus' Inhaled mRNA Therapeutic In Cystic Fibrosis Study Highlights Potential Amid Competitive Landscape: Analyst
↗
June 07, 2024
Arcturus Therapeutics shared Phase 1 and Phase 1b trial results for ARCT-032, an inhaled mRNA therapeutic for cystic fibrosis, showing FEV1 improvements and safety .
Via
Benzinga
Vertex Presents New Data at the European Cystic Fibrosis Conference Demonstrating Significant Benefits of Treatment with TRIKAFTA®
June 07, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Large Cap BIopharmaceuticals Overview
↗
June 03, 2024
As a defensive play healthcare is weighted at about 12% of the S&P 500.
Via
Talk Markets
Topics
Stocks
3 No-Brainer Stocks to Buy in June
↗
June 02, 2024
Now is the time to invest in these great stocks.
Via
The Motley Fool
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
76
77
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
